Objective To systematically review the published data on the culture yield of a repeat (second) percutaneous image-guided biopsy after negative initial biopsy in suspected spondylodiscitis. Materials and methods A systematic search was performed of the PubMed/Medline and Embase databases. The methodological quality of the studies included was assessed. The proportions of positive cultures among all initial biopsies and second biopsies (after a negative initial biopsy) were calculated for each study and assessed for heterogeneity (defined as I 2 > 50%). Results Eight studies, comprising a total of 107 patients who underwent a second percutaneous image-guided biopsy after a culture-negative initial biopsy in suspected spondylodiscitis, were included. All eight studies were at risk of bias and were concerning with regard to applicability, particularly patient selection, flow of patients through the study, and timing of the biopsy. The proportions of positive cultures among all initial biopsies ranged from 10.3 to 52.5%, and were subject to heterogeneity (I 2 = 73.7%). The proportions of positive cultures among all second biopsies after negative initial biopsy ranged from 0 to 60.0%, and were not subject to heterogeneity (I 2 = 38.7%). Conclusion Although a second percutaneous image-guided biopsy may have some value in patients with suspected spondylodiscitis, its exact value remains unclear, given the available poor-quality evidence. Future well-designed studies are needed to determine the role of a second percutaneous image-guided biopsy in this setting. Such studies should clearly describe the spectrum of patients that was selected for a second percutaneous image-guided biopsy, the method of biopsy, and differences compared with the first biopsy, if any.
Introduction
Spondylodiscitis refers to infection of the vertebrae and intervertebral disc [1] . The incidence of spondylodiscitis is approximately 2.4 cases per 100,000 population [2, 3] , and is on a steady rise owing to an aging population with inherent co-morbidities, and improved case ascertainment, particularly related to the widespread use of magnetic resonance imaging (MRI) [1] . Because of its nonspecific presentation, a delay of 6-8 weeks between the onset of symptoms and diagnosis is not unusual [1, 2] . However, because spondylodiscitis can be complicated by abscess formation, orthopedic complications (vertebral collapse and hyperkyphosis), neurological complications (motor weakness or paralysis), and even death (in approximately 6%) [1, 2] , timely diagnosis and treatment initiation are essential. Current Infectious Diseases Society of America (IDSA) guidelines recommend performing spine MRI and obtaining blood cultures in all patients with suspected spondylodiscitis [4] [5] [6] . The same guidelines also recommend an image-guided biopsy when a microbiological diagnosis has not been established by blood cultures or serological tests [4, 5] . A recent meta-analysis showed the culture yield of the initial imageguided biopsy in spondylodiscitis to be approximately 48% [7] . However, when both blood and biopsy cultures remain negative, it is unclear whether empirical antibiotic therapy should be started, if a repeat (second) image-guided biopsy should be performed, or if more invasive procedures such as percutaneous endoscopic discectomy and drainage (PEDD) or open excisional biopsy should be considered [7] . The advantage of a second image-guided biopsy is that it is less invasive than PEDD or an open excisional biopsy. However, because of the limited number of studies on this topic with relatively small sample sizes and heterogeneous methodology, the culture yield of a second image-guided biopsy is still unclear. Theoretically, if the patient spectrum and technical factors related to the biopsy are the same for the first and second attempts, the culture yields will be the same. However, this may not be the case in clinical practice. Information on the culture yield of a second image-guided biopsy, as performed in clinical practice, is crucial for evidence-based clinical decisionmaking. Therefore, the aim of this study was to systematically review published data on the culture yield of a second percutaneous image-guided biopsy after a negative initial biopsy in patients with suspected spondylodiscitis.
Materials and methods

Search strategy
The PubMed/Medline and Embase databases were systematically searched for articles on the culture yield of a second percutaneous image-guided biopsy after a negative initial biopsy in suspected spondylodiscitis. The search comprised a combination of the search terms Bspondylodiscitis OR spondylodiskitis OR discitis OR diskitis OR spondylitis OR spinal osteomyelitis OR vertebral osteomyelitis^AND Bbiopsy OR biopsies OR aspiration OR aspirations OR sample OR samples OR sampling OR samplings^AND Bcomputed tomography OR computerized tomography OR CT OR CT-guided OR fluoroscopic OR percutaneous.^No date restriction was applied. The search was updated to 18 November 2017. References of articles that remained after the selection process were screened for potentially suitable additional articles.
Study selection
Studies investigating the culture yield of a second percutaneous image-guided biopsy after a negative initial biopsy in suspected spondylodiscitis were eligible for inclusion. No language restriction was applied. Conference abstracts, case reports or series, editorials or letters, review articles, and metaanalyses were excluded. Articles that only reported the culture yield of the initial percutaneous, image-guided biopsy and that not did report or allow for the extraction of the culture yield of the second biopsy after a negative initial biopsy, were excluded. Articles that only included patients who underwent aspiration of postoperative paraspinal fluid collections or PEDD were excluded. When the same patient data were presented in more than one article, the article with the largest number of patients was selected. Three researchers (Ö.K, H.J.A.A., and T.C.K.) reviewed the titles and abstracts of the retrieved articles in consensus, applying the previously mentioned inclusion and exclusion criteria. Clearly ineligible articles were excluded at this stage. Subsequently, the same three researchers jointly reviewed the full text version of the remaining articles to determine their eligibility for inclusion.
Study quality
Methodological quality of the studies included was assessed using the Quality Assessment of Studies of Diagnostic Accuracy Included in Systematic Reviews (QUADAS)-2 tool [8] . The QUADAS-2 tool comprises four domains: patient selection, index test, reference standard, and flow and timing [8] . Each domain is assessed in terms of risk of bias, and the first three domains are also assessed in terms of concerns regarding applicability [8] . In the present study, imageguided biopsy and microbiological culture can be considered as both index test and reference test. Therefore, index test and reference standard were combined into one domain called Bbiopsy^for both risk of bias and applicability assessment. Risk of bias and concerns about applicability for each domain were judged to be Bhigh,^Bunclear,^or Blow.^If a study is judged as Blow^on all domains relating to bias or applicability, then it is appropriate to have an overall judgment of Blow risk of bias^or Blow concern regarding applicability^for that study [8] . If a study is judged to be Bhigh^or Bunclear^in one or more domains, then it may be judged to be Bat risk of biasô r as having Bconcerns regarding applicability^ [8] .
Statistical analysis
The proportions of positive cultures (i.e., cultures with isolated bacteria in the biopsy) among all initial biopsies and second biopsies (after a negative initial biopsy) were calculated for each individual study. Heterogeneity in positive culture yields across individual studies was assessed using the I 2 statistic, with heterogeneity defined as I 2 > 50% [9] . Statistical analyses were performed using Comprehensive Meta-Analysis Version 3 software (Biostat, Englewood, IL, USA). 
Results
Literature search
The systematic search yielded 1,300 articles from PubMed/Medline and 920 articles from Embase. After reviewing titles and abstracts, 78 PubMed/Medline indexed articles and 62 Embase indexed articles remained. After discarding duplicates, 93 potentially eligible articles remained, and these were retrieved in fulltext format. After reviewing the full-text article, 85 articles were excluded because they only reported the culture yield of the initial percutaneous image-guided biopsy and did not report or allow for the extraction of the culture yield of the repeat biopsy after a negative initial biopsy. Finally, eight studies remained [10] [11] [12] [13] [14] [15] [16] [17] , comprising a total of 107 patients who underwent a second percutaneous image-guided biopsy after a negative initial biopsy in suspected spondylodiscitis. The characteristics of these studies are displayed in Tables 1 and 2 .
Methodological quality assessment
Results of the quality assessment using the QUADAS-2 tool are displayed in Table 3 . Overall, all studies were at risk of bias and all studies had concerns regarding applicability.
There was a high risk of bias in the domain patient selection in 7 studies [10] [11] [12] [13] [14] [15] [16] , because only a minority of patients with negative initial biopsy cultures underwent a second biopsy and it was unclear why these patients were selected for repeat biopsy. There was an unclear risk of bias and applicability concern in the domain of biopsy in 7 studies, because they did not describe sufficient details on how percutaneous image-guided biopsy was performed in terms of image guidance, needle size, and number of biopsy samples acquired [10] [11] [12] [14] [15] [16] [17] . There was unclear risk of bias in the domain of flow and timing in all 8 studies [10] [11] [12] [13] [14] [15] [16] [17] , because of the time frame between MRI, the first biopsies and second biopsies were not described. In addition, in 7 studies it was unclear if patients received antibiotic treatment between the first and second biopsies [10] [11] [12] [13] [14] [15] 17] . There was an unclear applicability concern in the domain of patient selection in all 8 studies [10] [11] [12] [13] [14] [15] [16] [17] , because it was u n c l e a r i f p a t i e n t s w i t h a p r e v i o u s h i s t o r y o f spondylodiscitis were included, which patients were selected for second biopsy, and which of these patients had already been treated with antibiotics. In addition, in 4 studies it was unclear if MRI had been performed at all [12, 13, 15, 17] , in 4 other studies no (clear) MRI criteria for spondylodiscitis were reported [10, 11, 14, 16] , and in 2 The following signaling questions were used to assess the risk of bias and applicability concerns (which were then scored as high risk, low risk, or unclear):
Risk of bias: studies it was unclear whether patients with positive blood cultures before biopsy were excluded [10, 16] .
Culture yield of the repeat biopsy
Culture yields of initial and second biopsies for each individual study are displayed in Table 4 . The proportions of positive cultures among all initial biopsies (n = 507) ranged from 10.3 to 52.5% (with I 2 = 73.7%). The proportions of positive cultures among all second biopsies (n = 107) ranged from 0 to 60.0% (with I 2 = 38.7%; Fig. 1 ). Antibiotics were given after the first negative biopsy in 3 cases, and no antibiotics were given to the other case, which turned out to be culture-positive This systematic review included 8 studies, comprising a total sample size of 107 patients who underwent a second image-guided biopsy after a culture-negative initial biopsy in suspected spondylodiscitis. The positive culture yield of a second CT-guided biopsy ranged between approximately 10 and 50% of the studies included. However, these percentages should be interpreted cautiously because the overall quality of the studies included was poor to moderate, with several important methodological concerns. First, in 7 studies, only a minority of patients with a negative initial biopsy cultures underwent a second biopsy [10] [11] [12] [13] [14] [15] [16] . As 6 of these 7 studies were performed retrospectively [10-13, 15, 16] , the decision to rebiopsy was most likely based on clinical and radiological grounds, which may include insufficient treatment response and disease extent on MRI (e.g., the presence of large paravertebral phlegmon and/or abscess). These factors might overestimate the culture yield if extrapolated to all patients with a negative initial biopsy culture. Although the culturepositive rebiopsy yields do reflect clinical practice, the exact reasons why the patients in these studies were rebiopsied, remain unclear. Furthermore, from the 8 studies included, it was unclear how many of the patients with culture-negative initial biopsies eventually had positive blood cultures, how many underwent PEDD or open biopsy, and how many received empirical antibiotic therapy without any further diagnostic interventions [10] [11] [12] [13] [14] [15] [16] [17] . Second, there was poor reporting on the use and interpretation of MRI before biopsy. MRI is regarded as the imaging method of choice for the detection of spondylodiscitis and the discrimination from other conditions such as non-infectious inflammatory and degenerative disease that may simulate spinal infection [18] . For these reasons, IDSA guidelines recommend performing spine MRI before biopsy in all patients with suspected spondylodiscitis [4] [5] [6] . However, 4 studies did not report if MRI was performed [12, 13, 15, 17] and the 4 other studies did not report (clear) MRI criteria for spondylodiscitis [10, 11, 14, 16] . In addition, none of the eight studies included reported the time interval between MRI and biopsy. This rather poor prebiopsy MRI assessment may have negatively affected the culture yields because of potential data contamination with spondylodiscitis mimickers such as Modic type 1 degeneration, acute Schmorl node, and (osteoporotic) fractures [18] . Third, none of the 8 studies reported if patients with a previous history of spondylodiscitis had been excluded. MRI findings in these patients are nonspecific, correlate poorly with clinical and laboratory findings, and may overestimate the diagnosis of spondylodiscitis [19] . This issue may have affected culture yields. Fourth, seven of the eight studies included reported variable anatomical targets for biopsy (disc, vertebral corpus, and/or paravertebral soft tissue) [11] [12] [13] [14] [15] [16] [17] , whereas one study did not report which anatomical target was biopsied [10] . Variation in anatomical targets may also have affected culture yields. On the other hand, a previous study has shown that there were no statistically significant differences between the yields of endplate-disc, disc-only, and paravertebral soft-tissue biopsies [20] . Despite the variations in patient populations and methodology among the studies included, proportions of positive culture yields among second biopsies were statistically homogeneous, but this may be due to the relatively small sample sizes of the studies included. This systematic review had several limitations. First, although 93 potentially eligible articles were considered after screening titles and abstracts, only 8 studies with 107 patients who underwent repeat biopsy, remained for analysis. Second, owing to the low number of studies and underreported data, it was not possible to perform further subgroup analyses to determine if any clinical, laboratory, and/or imaging parameters are associated with positive repeat biopsy cultures. Third, although the culture yield of second biopsy was determined, it remains unclear which strategy (i.e., additional blood culture, second biopsy, PEDD, open biopsy, and/or empirical antibiotic therapy without any further diagnostic interventions) is most (cost-)effective in patients with a culture-negative initial biopsy. Thus, future prospective studies with larger sample sizes are needed.
Discussion
In conclusion, although a second percutaneous imageguided biopsy may have some value in patients with suspected spondylodiscitis, its exact value remains unclear given the poor-quality evidence available. Future well-designed studies are needed to determine the role of a second percutaneous image-guided biopsy in this setting. Such studies should clearly describe the spectrum of patients that was selected for a second percutaneous image-guided biopsy, the method of biopsy, and differences compared with the first biopsy, if any. 
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